Tigen
Eileen Pernot is a lead scientific writer with experience in writing clinical documents for oncology studies. Eileen has a Ph.D. in Molecular Biology from Université libre de Bruxelles and a background in managing clinical projects in oncology and epidemiology. Eileen has also worked on international projects related to ionizing radiation epidemiology and has a strong background in medical and scientific writing for pharmaceutical companies.
Tigen
We are a clinical-stage biotech company in the field of cell therapies to cure cancer. We are a disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class capabilities and a long-term perspective to the benefit of patients and society.